Sex differences in the rate and factors for elevated depressive symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis

Read full text
Authors: Hayley Riel, Francisca Lois Jacobo, Charles N. Bernstein, James M. Bolton, John D. Fisk, Lesley A. Graff, Carol Ann Hitchon, Chantel D. Mayo, Scott B. Patten, Ruth Ann Marrie, Kaarina Kowalec, CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease
Cited by: 0
References: 55

Abstract

In immune-mediated inflammatory diseases (IMID), females report elevated depressive symptoms more frequently than males. We examined clinical and sociodemographic factors associated with elevated depressive symptoms in IMID and whether endorsement of individual depressive symptoms differed by sex. This study included 652 individuals with an IMID from Manitoba, Canada. Depressive symptoms were measured using the PHQ-9 and HADS-D, with IMID-specific cut-offs to identify elevated depression. Elevated depressive symptoms were present in 234 participants (36%). Females did not show higher odds of elevated depression than males. Males were more likely to endorse the HADS-D item on cheerfulness. Smoking and anxiety symptoms, but not sex, were associated with elevated depressive symptoms. These findings may help identify high-risk individuals with an IMID and comorbid elevated depressive symptoms and guide intervention.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Tryptophan and brain disorders Mental Health Treatment and Access

Publication details

Journal / source
Journal of Health Psychology
Volume
31
Issue
9
Pages
3822–3843
Publication date
16 January 2026
Language
EN